定量检测E-cadherin基因启动子区甲基化芯片的建立-东南大学学报医学版

定量检测E-cadherin基因启动子区甲基化芯片的建立

单位：1.东南大学,临床医学院,江苏,南京,210009； 2.东南大学,生物科学与医学工程系,江苏,南京,210096

分类号：Q78

出版年·卷·期（页码）：2006·25·第三期（182-187）

摘要：

目的:拟建立一种能够定量检测抑癌基因E-cadherin甲基化改变的基因芯片.方法:用亚硫酸氢盐处理基因组DNA,并以此为模板进行PCR扩增.目的序列中未甲基化的CpG住点被翻转成TpG,而甲基化的CpG位点保持不变.设计5组探针构建一种检测E-cadherin基因启动子区17个CpG住点甲基化改变的芯片,每组探针包括一对非甲基化探针和甲基化探针,检测相邻的3或4个CpG位点.结果:绘制标准曲线显示,芯片上探针的可重复性和精确性很好,并定量检测了1例白血病样本的甲基化改变.结论:基因芯片能够作为一种定量检测基因多个CpG位点甲基化改变的有效工具,并用于肿瘤的研究.

Objective To establish a microarray-based method for quantificationally detecting methylation changes of a tumor suppressor gene E-cadherin.Methods This method used bisulfite-modified DNA as a template for PCR amplification,resulting in conversion of unmethylated cytosine,but not methylated cytosine,into thymine within CpG islands of interest.Five sets of oligonucleotide probes were designed to fabricate a DNA microarray to detect 17 CpG sites in the promoter of E-cadherin gene,each set contained a pair of methylated and unmethylated oligonucleotides for interrogating 3 or 4 CpG sites in close proximity.Results By drawing a standard curve we found the accuracy and reproducibility of the probes designed for microarray hybridization was very good.This standard curve was used to calibrate the levels of methylation changes detected in a leukemia sample by microarray assay.Conclusion Microarray assay can be applied as a useful tool for mapping methylation changes in multiple CpG loci and for researching cancer.

参考文献：

[1] MOMPARLER R L, BOVENZI V. DNA methylation and cancer. 2000(2). doi:10.1002/(SICI)1097-4652(200005)183:2&lt, 145::AID-JCP1&gt, 3.0.CO, 2-V
[2] COUNTS J L, GOODMAN J I. Alterations in DNA methylation may play a variety of roles in carcinogenesis. 1995(1). doi:10.1016/0092-8674(95)90228-7
[3] GRAFF J R, HERMAN J G, LAPIDUS R G. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas, 1995
[4] MELKI J R, VINCENT P C, BROWN R D. Hypermethylation of E-cadherin in leukemia. 2000
[5] BICKLE T A, KRUGER D H. Biology of DNA restriction, 1993
[6] KANE M F, LODA M, GAIDA G M. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1in sporadic colon tumors and mismatch repair-defective human tumor cell lines. 1997
[7] FROMMER M, MCDONALD L E, MILLAR D S. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands, 1992
[8] HERMAN J G, GRAFF J R, MYOHANEN S. Methylation-specific PCR:a novel PCR assay for methylation status of CpG islands. 1996
[9] GONZALGO M L, JONES P A. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). 1997. doi:10.1093/nar/25.12.2529
[10] 邓大钧, 邓国仁, 吕有勇. 变性高效液相色谱法检测CpG岛胞嘧啶甲基化. 中华医学杂志2001(3)
[11] HUANG T H M, PERRY M R, LAUX D E. Methylation prof iling of CpG islands in human breast cancer cells. 1999(3). doi:10.1093/hmg/8.3.459
[12] GITAN R S, SHI H, CHEN C M. Methylation-specific oligonucleotide microarray:a new potential for high-throughput methylation analysis. 2002(1)
[13] SCHOLZ C, NIMMRICH I, BURGER M. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis. 2005. doi:10.1007/s00277-004-0969-1
[14] MELKI J R, CLARK S J. DNA methylation changes in leukaemia. 2002(12). doi:10.1016/S1044-579X(2)00055-X

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录